메뉴 건너뛰기




Volumn 12, Issue 5, 2015, Pages

Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; GROUPS BY AGE; HUMAN; IMMUNITY; IMMUNIZATION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; META ANALYSIS (TOPIC); MODEL; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SEASONAL INFLUENZA; SENSITIVITY ANALYSIS; THAILAND; COST BENEFIT ANALYSIS; ECONOMICS; PREVENTIVE HEALTH SERVICE; SEASON; STATISTICS AND NUMERICAL DATA; VACCINATION;

EID: 84930532938     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001829     Document Type: Article
Times cited : (36)

References (57)
  • 1
    • 84877145716 scopus 로고    scopus 로고
    • Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies
    • Jit M, Newall AT, Beutels P, Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccin Immunother 2013;9:834–840. doi: 10.4161/hv.23637 23357859
    • (2013) Hum Vaccin Immunother , vol.9 , pp. 834-840
    • Jit, M.1    Newall, A.T.2    Beutels, P.3
  • 2
    • 84886619222 scopus 로고    scopus 로고
    • Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study
    • Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ, Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 2013;10:e1001527. doi: 10.1371/journal.pmed.1001527 24115913
    • (2013) PLoS Med , vol.10 , pp. e1001527
    • Baguelin, M.1    Flasche, S.2    Camacho, A.3    Demiris, N.4    Miller, E.5    Edmunds, W.J.6
  • 3
    • 84857954427 scopus 로고    scopus 로고
    • A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research
    • Longini IM, JrA theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research. Pediatrics 2012;129 Suppl 2:S63–S67. doi: 10.1542/peds.2011-0737D 22383483
    • (2012) Pediatrics , vol.129 , pp. S63-S67
    • Longini, I.M.1
  • 4
    • 84878964529 scopus 로고    scopus 로고
    • Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty
    • Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP, Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine 2013;31:3079–3089. doi: 10.1016/j.vaccine.2013.04.052 23684837
    • (2013) Vaccine , vol.31 , pp. 3079-3089
    • Ndeffo Mbah, M.L.1    Medlock, J.2    Meyers, L.A.3    Galvani, A.P.4    Townsend, J.P.5
  • 5
    • 69949189626 scopus 로고    scopus 로고
    • Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States
    • Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM, JrStrategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol 2009;170:679–686. doi: 10.1093/aje/kwp237 19679750
    • (2009) Am J Epidemiol , vol.170 , pp. 679-686
    • Basta, N.E.1    Chao, D.L.2    Halloran, M.E.3    Matrajt, L.4    Longini, I.M.5
  • 6
    • 50849106695 scopus 로고    scopus 로고
    • Estimating the impact of childhood influenza vaccination programmes in England and Wales
    • Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ, Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008;26:5321–5330. doi: 10.1016/j.vaccine.2008.06.101 18647634
    • (2008) Vaccine , vol.26 , pp. 5321-5330
    • Vynnycky, E.1    Pitman, R.2    Siddiqui, R.3    Gay, N.4    Edmunds, W.J.5
  • 7
    • 84856323665 scopus 로고    scopus 로고
    • Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales
    • Pitman RJ, White LJ, Sculpher M, Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2012;30:1208–1224. doi: 10.1016/j.vaccine.2011.11.106 22178725
    • (2012) Vaccine , vol.30 , pp. 1208-1224
    • Pitman, R.J.1    White, L.J.2    Sculpher, M.3
  • 9
    • 84902363408 scopus 로고    scopus 로고
    • Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years
    • Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, et al. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years. Influenza Other Respir Viruses 2014;8:463–468. doi: 10.1111/irv.12233 24490684
    • (2014) Influenza Other Respir Viruses , vol.8 , pp. 463-468
    • Dawood, F.S.1    Prapasiri, P.2    Areerat, P.3    Ruayajin, A.4    Chittaganpitch, M.5    Muangchana, C.6
  • 10
    • 84155162558 scopus 로고    scopus 로고
    • Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
    • Osterholm MT, Kelley NS, Sommer A, Belongia EA, Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44. doi: 10.1016/S1473-3099(11)70295-X 22032844
    • (2012) Lancet Infect Dis , vol.12 , pp. 36-44
    • Osterholm, M.T.1    Kelley, N.S.2    Sommer, A.3    Belongia, E.A.4
  • 11
    • 0032925086 scopus 로고    scopus 로고
    • A Bayesian approach to stochastic cost-effectiveness analysis
    • Briggs AH, A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999;8:257–261. 10348420
    • (1999) Health Econ , vol.8 , pp. 257-261
    • Briggs, A.H.1
  • 12
    • 52649097540 scopus 로고    scopus 로고
    • Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)
    • Barton GR, Briggs AH, Fenwick EA, Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health 2008;11:886–897. doi: 10.1111/j.1524-4733.2008.00358.x 18489513
    • (2008) Value Health , vol.11 , pp. 886-897
    • Barton, G.R.1    Briggs, A.H.2    Fenwick, E.A.3
  • 13
    • 84875454300 scopus 로고    scopus 로고
    • Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information
    • Sadatsafavi M, Bansback N, Zafari Z, Najafzadeh M, Marra C, Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value Health 2013;16:438–448. doi: 10.1016/j.jval.2012.10.018 23538197
    • (2013) Value Health , vol.16 , pp. 438-448
    • Sadatsafavi, M.1    Bansback, N.2    Zafari, Z.3    Najafzadeh, M.4    Marra, C.5
  • 14
    • 79952600976 scopus 로고    scopus 로고
    • Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza
    • Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, Ferguson NM, et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci U S A 2011;108:2825–2830. doi: 10.1073/pnas.1008895108 21282645
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 2825-2830
    • Cauchemez, S.1    Bhattarai, A.2    Marchbanks, T.L.3    Fagan, R.P.4    Ostroff, S.5    Ferguson, N.M.6
  • 15
    • 41349106559 scopus 로고    scopus 로고
    • Time lines of infection and disease in human influenza: a review of volunteer challenge studies
    • Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775–785. doi: 10.1093/aje/kwm375 18230677
    • (2008) Am J Epidemiol , vol.167 , pp. 775-785
    • Carrat, F.1    Vergu, E.2    Ferguson, N.M.3    Lemaitre, M.4    Cauchemez, S.5    Leach, S.6
  • 17
    • 84885948261 scopus 로고    scopus 로고
    • Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis
    • Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR, Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. Vaccine 2013;31:5168–5177. doi: 10.1016/j.vaccine.2013.08.056 24012574
    • (2013) Vaccine , vol.31 , pp. 5168-5177
    • Breteler, J.K.1    Tam, J.S.2    Jit, M.3    Ket, J.C.4    De Boer, M.R.5
  • 19
    • 84930522664 scopus 로고    scopus 로고
    • McKenzie J, Ryan R, Di Tanna GL. Cochrane Consumer and Communication Review Group: cluster randomised controlled trials. Available: http://cccrg.cochrane.org/sites/cccrg.cochrane.org/files/uploads/ClusterRCTs.pdf. Accessed 23 April 2015.
  • 20
    • 84899765876 scopus 로고    scopus 로고
    • Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia
    • Saha S, Chadha M, Al Mamun A, Rahman M, Sturm-Ramirez K, Chittaganpitch M, et al. Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia. Bull World Health Organ 2014; 92:318–330. doi: 10.2471/BLT.13.124412 24839321
    • (2014) Bull World Health Organ , vol.92 , pp. 318-330
    • Saha, S.1    Chadha, M.2    Al Mamun, A.3    Rahman, M.4    Sturm-Ramirez, K.5    Chittaganpitch, M.6
  • 22
    • 84885748696 scopus 로고    scopus 로고
    • Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong
    • Zhou Y, Lau EH, Ip DK, Nishiura H, Leung GM, Seto WH, et al. Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. Am J Epidemiol 2013;178:1313–1318. doi: 10.1093/aje/kwt120 23978528
    • (2013) Am J Epidemiol , vol.178 , pp. 1313-1318
    • Zhou, Y.1    Lau, E.H.2    Ip, D.K.3    Nishiura, H.4    Leung, G.M.5    Seto, W.H.6
  • 23
    • 84864543092 scopus 로고    scopus 로고
    • Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
    • Lugner AK, van Boven M, de Vries R, Postma MJ, Wallinga J, Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012;345:e4445. doi: 10.1136/bmj.e4445 22791791
    • (2012) BMJ , vol.345 , pp. e4445
    • Lugner, A.K.1    van Boven, M.2    de Vries, R.3    Postma, M.J.4    Wallinga, J.5
  • 25
    • 84930522665 scopus 로고    scopus 로고
    • Program for Appropriate Technology in Health, World Health Organization, Health Systems Research Institute, Mahidol University. An assessment of vaccine supply chain and logistics systems in Thailand. Program for Appropriate Technology in Health; 2011. Available: http://www.path.org/publications/files/TS_opt_vac_sup_thai.pdf. Accessed 23 April 2015.
  • 26
    • 84930522666 scopus 로고    scopus 로고
    • Riewpaiboon A. Standard cost lists for health technology assessment. Nonthaburi (Thailand): Health Intervention and Technology Assessment Program; 2011. Available: http://www.hitap.net/costingmenu/. Accessed 23 April 2015.
  • 28
    • 79960337754 scopus 로고    scopus 로고
    • Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
    • Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M, et al. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343:d3908. doi: 10.1136/bmj.d3908 21750072
    • (2011) BMJ , vol.343 , pp. d3908
    • Dieleman, J.1    Romio, S.2    Johansen, K.3    Weibel, D.4    Bonhoeffer, J.5    Sturkenboom, M.6
  • 29
    • 84930522667 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. Vaccines for Children Program (VFC): CDC vaccine price list. Centers for Disease Control and Prevention; 2014. Available: http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/. Accessed 23 April 2015.
  • 30
    • 43249095884 scopus 로고    scopus 로고
    • Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States
    • Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States. Vaccine. 2008;26:2841–2848. doi: 10.1016/j.vaccine.2008.03.046 18462851
    • (2008) Vaccine , vol.26 , pp. 2841-2848
    • Luce, B.R.1    Nichol, K.L.2    Belshe, R.B.3    Frick, K.D.4    Li, S.X.5    Boscoe, A.6
  • 31
    • 84930486106 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
    • Tarride J-E, Burke N, Von Keyserlingk C, O’Reilly D, Xie F, Goeree R, Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res. 2012;4:287–298. doi: 10.2147/CEOR.S33444 23055756
    • (2012) Clinicoecon Outcomes Res , vol.4 , pp. 287-298
    • Tarride, J.-E.1    Burke, N.2    Von Keyserlingk, C.3    O’Reilly, D.4    Xie, F.5    Goeree, R.6
  • 32
    • 84930522668 scopus 로고    scopus 로고
    • Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    • Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, et al. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ. 2014 May 25. doi: 10.1007/s10198-014-0586-4
    • (2014) Eur J Health Econ
    • Damm, O.1    Eichner, M.2    Rose, M.A.3    Knuf, M.4    Wutzler, P.5    Liese, J.G.6
  • 33
    • 84930522669 scopus 로고    scopus 로고
    • Thai Ministry of Commerce Bureau of Trade and Economic Indices. Report for consumer price index of Thailand year 2007: base year 2011. Available: http://www.indexpr.moc.go.th/price_present/TableIndexG_region.asp?nyear=2550&Province_code=5&table_name=cpig_index_country&type_code=g&check_f=i&comm_code=0&Submit=+%B5%A1%C5%A7+. Accessed 23 April 2015.
  • 34
    • 84930522670 scopus 로고    scopus 로고
    • International Monetary Fund. World economic outlook database, October 2012: Thailand—national currency per current international dollar. Available: http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weorept.aspx?sy=2010&ey=2017&scsm=1&ssd=1&sort=country&ds=.&br=1&pr1.x=21&pr1.y=9&c=578&s=PPPEX&grp=0&a=. Accessed 23 April 2015.
  • 36
    • 84861413158 scopus 로고    scopus 로고
    • The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007–2010: the Ha Nam household cohort study I
    • Horby P, Mai le Q, Fox A, Thai PQ, Thi Thu Yen N, Thanh le T, et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007–2010: the Ha Nam household cohort study I. Am J Epidemiol. 2012;175:1062–1074. doi: 10.1093/aje/kws121 22411862
    • (2012) Am J Epidemiol , vol.175 , pp. 1062-1074
    • Horby, P.1    Mai le, Q.2    Fox, A.3    Thai, P.Q.4    Thi Thu Yen, N.5    Thanh le, T.6
  • 37
    • 0006407254 scopus 로고    scopus 로고
    • WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility
    • Lunn DJ, Thomas A, Best N, Spiegelhalter D, WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325–337. 10902901
    • (2000) Stat Comput , vol.10 , pp. 325-337
    • Lunn, D.J.1    Thomas, A.2    Best, N.3    Spiegelhalter, D.4
  • 38
    • 0026086848 scopus 로고    scopus 로고
    • Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses
    • Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB, Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1999;163:300–4. 1988512
    • (1999) J Infect Dis , vol.163 , pp. 300-304
    • Clover, R.D.1    Crawford, S.2    Glezen, W.P.3    Taber, L.H.4    Matson, C.C.5    Couch, R.B.6
  • 39
    • 77949329183 scopus 로고    scopus 로고
    • Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial
    • Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010;303:943–950. doi: 10.1001/jama.2010.250 20215608
    • (2010) JAMA , vol.303 , pp. 943-950
    • Loeb, M.1    Russell, M.L.2    Moss, L.3    Fonseca, K.4    Fox, J.5    Earn, D.J.6
  • 40
    • 0032516267 scopus 로고    scopus 로고
    • The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
    • Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338:1405–1412. 9580647
    • (1998) N Engl J Med , vol.338 , pp. 1405-1412
    • Belshe, R.B.1    Mendelman, P.M.2    Treanor, J.3    King, J.4    Gruber, W.C.5    Piedra, P.6
  • 41
    • 0033913482 scopus 로고    scopus 로고
    • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
    • Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168–75. 10657821
    • (2000) J Pediatr , vol.136 , pp. 168-175
    • Belshe, R.B.1    Gruber, W.C.2    Mendelman, P.M.3    Cho, I.4    Reisinger, K.5    Block, S.L.6
  • 42
    • 34347361688 scopus 로고    scopus 로고
    • Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia
    • Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26:619–28. 17596805
    • (2007) Pediatr Infect Dis J , vol.26 , pp. 619-628
    • Tam, J.S.1    Capeding, M.R.2    Lum, L.C.3    Chotpitayasunondh, T.4    Jiang, Z.5    Huang, L.M.6
  • 43
    • 75449104808 scopus 로고    scopus 로고
    • Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
    • Lum LC, Borja-Tabora CF, Breiman RF, Vesikari T, Sablan BP, Chay OM, et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine. 2010;28:1566–1574. doi: 10.1016/j.vaccine.2009.11.054 20003918
    • (2010) Vaccine , vol.28 , pp. 1566-1574
    • Lum, L.C.1    Borja-Tabora, C.F.2    Breiman, R.F.3    Vesikari, T.4    Sablan, B.P.5    Chay, O.M.6
  • 44
    • 84930522671 scopus 로고    scopus 로고
    • World Health Organization. Cost effectiveness and strategic planning (WHO-CHOICE): Cost-effectiveness thresholds. Available: http://www.who.int/choice/costs/CER_thresholds/en/. Accessed 23 April 2015.
  • 45
    • 0030045041 scopus 로고    scopus 로고
    • Evaluating new vaccines for developing countries. Efficacy or effectiveness?
    • Clemens J, Brenner R, Rao M, Tafari N, Lowe C, Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA. 1996;275:390–397. 8569019
    • (1996) JAMA , vol.275 , pp. 390-397
    • Clemens, J.1    Brenner, R.2    Rao, M.3    Tafari, N.4    Lowe, C.5
  • 46
    • 84878383598 scopus 로고    scopus 로고
    • Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?
    • Kulpeng W, Leelahavarong P, Rattanavipapong W, Sornsrivichai V, Baggett HC, Meeyai A, et al. Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context? Vaccine. 2013;31:2839–2847. doi: 10.1016/j.vaccine.2013.03.047 23588084
    • (2013) Vaccine , vol.31 , pp. 2839-2847
    • Kulpeng, W.1    Leelahavarong, P.2    Rattanavipapong, W.3    Sornsrivichai, V.4    Baggett, H.C.5    Meeyai, A.6
  • 47
    • 84859005282 scopus 로고    scopus 로고
    • Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand
    • Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P, Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Vaccine. 2012; 30:2839–2847. doi: 10.1016/j.vaccine.2012.02.047 22387220
    • (2012) Vaccine , vol.30 , pp. 2839-2847
    • Muangchana, C.1    Riewpaiboon, A.2    Jiamsiri, S.3    Thamapornpilas, P.4    Warinsatian, P.5
  • 48
    • 36049022594 scopus 로고    scopus 로고
    • Influenza virus transmission is dependent on relative humidity and temperature
    • Lowen AC, Mubareka S, Steel J, Palese P, Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007;3:1470–1476. 17953482
    • (2007) PLoS Pathog , vol.3 , pp. 1470-1476
    • Lowen, A.C.1    Mubareka, S.2    Steel, J.3    Palese, P.4
  • 49
    • 40849100084 scopus 로고    scopus 로고
    • Economic evidence of influenza vaccination in children
    • Savidan E, Chevat C, Marsh G, Economic evidence of influenza vaccination in children. Health Policy 2008;86:142–152. 18054109
    • (2008) Health Policy , vol.86 , pp. 142-152
    • Savidan, E.1    Chevat, C.2    Marsh, G.3
  • 50
    • 84872612562 scopus 로고    scopus 로고
    • Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model
    • Pitman RJ, Nagy LD, Sculpher MJ, Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Vaccine 2013;31:927–942. doi: 10.1016/j.vaccine.2012.12.010 23246550
    • (2013) Vaccine , vol.31 , pp. 927-942
    • Pitman, R.J.1    Nagy, L.D.2    Sculpher, M.J.3
  • 51
    • 42349094829 scopus 로고    scopus 로고
    • The global circulation of seasonal influenza A (H3N2) viruses
    • Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008; 320:340–346. doi: 10.1126/science.1154137 18420927
    • (2008) Science , vol.320 , pp. 340-346
    • Russell, C.A.1    Jones, T.C.2    Barr, I.G.3    Cox, N.J.4    Garten, R.J.5    Gregory, V.6
  • 52
    • 0037468827 scopus 로고    scopus 로고
    • Ecological and immunological determinants of influenza evolution
    • Ferguson NM, Galvani AP, Bush RM, Ecological and immunological determinants of influenza evolution. Nature 2003; 422:428–433. 12660783
    • (2003) Nature , vol.422 , pp. 428-433
    • Ferguson, N.M.1    Galvani, A.P.2    Bush, R.M.3
  • 55
    • 84902576162 scopus 로고    scopus 로고
    • The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model
    • Van Bellinghen LA, Meier G, Van Vlaenderen I, The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model. PLoS ONE 2014;9:e98437. doi: 10.1371/journal.pone.0098437 24905235
    • (2014) PLoS ONE , vol.9 , pp. e98437
    • Van Bellinghen, L.A.1    Meier, G.2    Van Vlaenderen, I.3
  • 56
    • 84965188416 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    • You J, Ming WK, Chan P, Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. BMC Infect Dis 2014;14:618. doi: 10.1186/s12879-014-0618-9 25420713
    • (2014) BMC Infect Dis , vol.14 , pp. 618
    • You, J.1    Ming, W.K.2    Chan, P.3
  • 57
    • 84861516997 scopus 로고    scopus 로고
    • Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine
    • Cowling BJ, Fang VJ, Nishiura H, Chan KH, Ng S, Ip DK, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012;54:1778–1783. doi: 10.1093/cid/cis307 22423139
    • (2012) Clin Infect Dis , vol.54 , pp. 1778-1783
    • Cowling, B.J.1    Fang, V.J.2    Nishiura, H.3    Chan, K.H.4    Ng, S.5    Ip, D.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.